This study is looking at a new treatment for people with type 2 diabetes, a condition where your body can't use sugar properly. The study will last for about 36 weeks. Participants need to be between 18 to 75 years old and should have a body mass index (BMI) of 25 to 50. BMI is a measure of body fat based on height and weight. Participants will receive weekly injections under the skin of either the new treatment or a placebo (a harmless pill that doesn't affect the body) and will be monitored for 36 weeks. They will also have a 4-week screening period and a 4-week follow-up period.

Key Points:

• The study lasts 44 weeks total (4 weeks screening, 36 weeks treatment, 4 weeks follow-up).
• Participants will receive injections every week.
• There are certain health conditions that may prevent participation, like severe heart issues or recent pancreatitis.

This is a double-blind study, meaning neither the participants nor the researchers know who is getting the actual treatment, to ensure results are unbiased.